Tenet Healthcare Corp (THC): who owns it and who trades it
As of Nov 16, 2026, THC insiders reported 34 open-market sales worth $63.2M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Saumya Sutaria (CEO), with $27.6M. 8 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Tenet Healthcare
From the latest filingsOverall: more selling than buying. Insiders mostly sold. Funds and famous investors were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns THC
677 funds and institutions reported THC shares worth $15.2B at the end of Q2 2026, about 94% of the company. The largest holder is BlackRock, Inc. with 10.2%.
Funds and institutions (13F) 94%Everyone else 6%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 8.74M | 10.15% | $1.6B | +0% |
| T. Rowe Price Associates | 7.96M | 9.24% | $1.5B | +6% |
| Boston Partners | 4.43M | 5.15% | $829M | +16% |
| Vanguard Portfolio Management LLC | 4.24M | 4.92% | $793M | -2% |
| FMR LLC (Fidelity) | 3.99M | 4.64% | $747M | -49% |
| Vanguard Capital Management LLC | 3.89M | 4.52% | $729M | -0% |
| State Street Corp | 2.75M | 3.19% | $515M | +1% |
| Glenview Capital Management, LLC | 2.24M | 2.60% | $418M | +47% |
| Geode Capital Management, LLC | 1.88M | 2.19% | $353M | -2% |
| Citadel Advisors LLC | 1.77M | 2.05% | $330M | +322% |
| Arrowstreet Capital, Limited Partnership | 1.71M | 1.98% | $320M | +154% |
| Ameriprise Financial Inc | 1.66M | 1.93% | $311M | +12% |
| Dimensional Fund Advisors LP | 1.45M | 1.68% | $271M | +21% |
| Invesco Ltd. | 1.42M | 1.64% | $265M | -21% |
| Victory Capital Management Inc | 1.24M | 1.44% | $232M | +61% |
| Norges Bank | 1.21M | 1.41% | $227M | – |
| AQR Capital Management LLC | 1.07M | 1.24% | $198M | -26% |
| Alliancebernstein L.P. | 910,270 | 1.06% | $172M | +30% |
| Manning & Napier Advisors LLC | 901,645 | 1.05% | $169M | – |
| Bank of America Corp | 854,858 | 0.99% | $160M | +11% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, THC insiders reported $0 of open-market purchases and $63.2M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Roy Blunt | Director | Sale | 1,000 | $293.00 | $293K | Form 4 |
| Sep 14, 2026 | J Robert Kerrey | Director | Sale | 2,502 | $264.62 | $662K | Form 4 |
| Sep 14, 2026 | J Robert Kerrey | Director | Sale | 5,483 | $263.04 | $1.4M | Form 4 |
| Sep 14, 2026 | J Robert Kerrey | Director | Sale | 4,025 | $264.10 | $1.1M | Form 4 |
| Sep 10, 2026 | Richard J Mark | Director | Sale | 10,000 | $263.42 | $2.6M | Form 4 |
| Sep 2, 2026 | Nadja West | Director | Sale | 1,152 | $258.80 | $298K | Form 4 |
| Aug 31, 2026 | Lisa Y Foo | Vice president | Sale | 24,000 | $266.32 | $6.4M | Form 4 |
| Aug 25, 2026 | Saumya Sutaria | CEO | Sale | 24,881 | $274.10 | $6.8M | Form 4 |
| Aug 25, 2026 | Saumya Sutaria | CEO | Sale | 17,220 | $273.34 | $4.7M | Form 4 |
| Aug 25, 2026 | Saumya Sutaria | CEO | Sale | 7,899 | $275.26 | $2.2M | Form 4 |
| Aug 24, 2026 | Cecil D Haney | Director | Sale | 1,300 | $278.03 | $361K | Form 4 |
| Aug 24, 2026 | Saumya Sutaria | CEO | Sale | 13,344 | $278.17 | $3.7M | Form 4 |
| Aug 24, 2026 | Saumya Sutaria | CEO | Sale | 36,656 | $278.90 | $10.2M | Form 4 |
| Aug 7, 2026 | Tammy Romo | Director | Sale | 2,500 | $260.83 | $652K | Form 4 |
| Aug 6, 2026 | Tammy Romo | Director | Sale | 4,922 | $264.15 | $1.3M | Form 4 |
| Aug 5, 2026 | Roy Blunt | Director | Sale | 600 | $262.68 | $158K | Form 4 |
| Jul 29, 2026 | Lisa Y Foo | Vice president | Sale | 10,000 | $258.03 | $2.6M | Form 4 |
| Jul 27, 2026 | Christopher S. Lynch | Director | Sale | 3,837 | $243.44 | $934K | Form 4 |
| Jul 27, 2026 | Paola M Arbour | Vice president | Sale | 10,878 | $243.90 | $2.7M | Form 4 |
| Jul 27, 2026 | James L Bierman | Director | Sale | 5,000 | $244.96 | $1.2M | Form 4 |
| May 28, 2026 | J Robert Kerrey | Director | Sale | 361 | $177.52 | $64.1K | Form 4 |
| May 28, 2026 | J Robert Kerrey | Director | Sale | 1,969 | $173.12 | $341K | Form 4 |
| May 28, 2026 | J Robert Kerrey | Director | Sale | 1,690 | $173.97 | $294K | Form 4 |
| May 28, 2026 | J Robert Kerrey | Director | Sale | 905 | $176.89 | $160K | Form 4 |
| May 28, 2026 | J Robert Kerrey | Director | Sale | 713 | $175.13 | $125K | Form 4 |
| May 27, 2026 | Nadja West | Director | Sale | 3,000 | $177.35 | $532K | Form 4 |
| Mar 11, 2026 | Paola M Arbour | Vice president | Sale | 6,500 | $238.43 | $1.5M | Form 4 |
| Mar 9, 2026 | Thomas W Arnst | Vice president | Sale | 4,714 | $238.42 | $1.1M | Form 4 |
| Mar 9, 2026 | Thomas W Arnst | Vice president | Sale | 3,286 | $239.46 | $787K | Form 4 |
| Mar 2, 2026 | R. Scott Ramsey | Principal Accounting Off | Sale | 1,398 | $233.69 | $327K | Form 4 |
| Mar 2, 2026 | R. Scott Ramsey | Principal Accounting Off | Sale | 2,125 | $230.98 | $491K | Form 4 |
| Mar 2, 2026 | R. Scott Ramsey | Principal Accounting Off | Sale | 4,494 | $233.21 | $1M | Form 4 |
| Mar 2, 2026 | Thomas W Arnst | Vice president | Sale | 24,000 | $234.04 | $5.6M | Form 4 |
| Dec 15, 2025 | Nadja West | Director | Sale | 2,178 | $197.47 | $430K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Saumya Sutaria | CEO, Director | – | $27.6M | Aug 25, 2026 |
| Lisa Y Foo | EVP, Chief Operating Officer | – | $9M | Aug 31, 2026 |
| Thomas W Arnst | EVP, Chief Admin. Officer & GC | – | $7.5M | Mar 9, 2026 |
| Paola M Arbour | EVP, Chief Information Officer | – | $4.2M | Jul 27, 2026 |
| J Robert Kerrey | Director | – | $4.2M | Sep 14, 2026 |
| Richard J Mark | Director | – | $2.6M | Sep 10, 2026 |
| Tammy Romo | Director | – | $2M | Aug 7, 2026 |
| R. Scott Ramsey | Principal Accounting Officer | – | $1.9M | Mar 2, 2026 |
| Nadja West | Director | – | $1.3M | Sep 2, 2026 |
| James L Bierman | Director | – | $1.2M | Jul 27, 2026 |
| Christopher S. Lynch | Director | – | $934K | Jul 27, 2026 |
| Roy Blunt | Director | – | $451K | Nov 11, 2026 |
| Cecil D Haney | Director | – | $361K | Aug 24, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
THC short interest
Low short interest. 2.2% of THC shares are sold short: about 1 share in 45. Over the last 12 reports the number of shares short went down 29%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 1.78M THC shares were sold short, 2.2% of the shares outstanding, down 3.3% from the report before. At the average daily volume of 811,923 shares, buying them all back would take about 2.2 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 1.78M | 2.23% | -3% | 811,923 | 2.2 |
| Oct 15, 2026 | 1.84M | 2.28% | +0% | 552,659 | 3.3 |
| Sep 30, 2026 | 1.83M | 2.27% | -9% | 862,621 | 2.1 |
| Sep 15, 2026 | 2.02M | 2.50% | +7% | 717,517 | 2.8 |
| Aug 31, 2026 | 1.89M | 2.34% | -25% | 746,597 | 2.5 |
| Aug 14, 2026 | 2.52M | 3.13% | -21% | 812,116 | 3.1 |
| Jul 31, 2026 | 3.20M | 3.98% | +7% | 1.59M | 2.0 |
| Jul 15, 2026 | 2.98M | 3.46% | -20% | 1.33M | 2.2 |
| Jun 30, 2026 | 3.74M | 4.34% | -8% | 1.31M | 2.9 |
| Jun 15, 2026 | 4.06M | 4.71% | +24% | 1.52M | 2.7 |
| May 29, 2026 | 3.28M | 3.80% | +31% | 1.43M | 2.3 |
| May 15, 2026 | 2.50M | 2.90% | +14% | 1.63M | 1.5 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded THC
Since Nov 17, 2024, 2 members of Congress reported 3 purchases and 4 sales of THC. The latest was a sale by Jonathan L. Jackson on Apr 20, 2026, reported May 27, 2026.
Purchases 3Sales 4
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Jonathan L. Jackson (D-IL) | Sale | $15K–$50K | Joint | May 27, 2026 | Report |
| Apr 15, 2026 | Jonathan L. Jackson (D-IL) | Sale | $1K–$15K | Spouse | May 27, 2026 | Report |
| Feb 11, 2026 | Jonathan L. Jackson (D-IL) | Partial sale | $1K–$15K | Spouse | Mar 12, 2026 | Report |
| Dec 10, 2025 | Jonathan L. Jackson (D-IL) | Purchase | $15K–$50K | Joint | Jan 8, 2026 | Report |
| Sep 3, 2025 | Jonathan L. Jackson (D-IL) | Purchase | $1K–$15K | Spouse | Oct 15, 2025 | Report |
| Aug 4, 2025 | Lisa C. McClain (R-MI) | Sale | $1K–$15K | Spouse | Sep 12, 2025 | Report |
| Jun 11, 2025 | Lisa C. McClain (R-MI) | Purchase | $1K–$15K | Spouse | Aug 13, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Tenet Healthcare company events
Tenet Healthcare filed 12 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership). The latest was on Oct 29, 2026.
- Oct 29, 2026ResultsReleased financial results. Filing
- Sep 22, 2026AgreementThe information set forth below in Item 2.03 is incorporated by reference into this Item 1.01. Filing
- Sep 8, 2026AnnouncementThe Company issued a notice of conditional full redemption to the holders of its 2027 Notes and a notice of conditional partial redemption to the holders of its 2028 Notes. Filing
- Jul 23, 2026ResultsReleased financial results. Filing
- May 29, 2026VoteReported shareholder vote results. Filing
- Apr 30, 2026ResultsReleased financial results. Filing
- Apr 10, 2026LeadershipTenet Healthcare Corporation and Paola Arbour entered into a Retirement Transition Agreement and General Release that provides that Ms. Arbour will retire from her role as Executive Vice President and Chief Information Officer effective December 31, 2026, but will remain employed on a part-time… Filing
- Mar 30, 2026LeadershipTenet Healthcare Corporation previously disclosed that its Senior Vice President & Controller (Principal Accounting Officer), R. Scott Ramsey, provided notice of his plan to retire effective March 31, 2026. Filing
- Feb 11, 2026ResultsReleased financial results. Filing
- Feb 2, 2026AnnouncementThe Company entered into that certain Omnibus Agreement, by and among the Company, Conifer Health Solutions, LLC, Conifer Revenue Cycle Solutions, LLC, and CommonSpirit Health (formerly known as Catholic Health Initiatives). Filing
- Nov 24, 2025LeadershipStephen H. Rusckowski notified Tenet Healthcare Corporation of his decision to resign from the Company’s board of directors, effective immediately. Filing
- Nov 18, 2025AgreementThe information set forth below in Item 2.03 is incorporated by reference into this Item 1.01. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Tenet Healthcare financials
Famous investors that hold THC
8 of the 50 well-known investors we track reported holding THC in their latest 13F filing. The largest position is Larry Robbins's, worth $523M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Larry Robbins · Glenview Capital Management | Q3 2026 | 2.05M | $523M | 9.3% | -8% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 1.75M | $447M | 0.2% | -1% |
| Israel Englander · Millennium Management | Q3 2026 | 412,523 | $105M | 0.1% | -11% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 134,753 | $34.4M | 0.2% | New |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 106,922 | $27.3M | 0.1% | +152% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 31,323 | $8M | 0.0% | -83% |
| Bill Nygren · Harris Associates (Oakmark) | Q3 2026 | 2,400 | $613K | 0.0% | No change |
| Lee Ainslie · Maverick Capital | Q3 2026 | 2,133 | $545K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Tenet Healthcare Corp (THC) stock
Who owns the most THC stock?
The largest reported owner of Tenet Healthcare Corp (THC) is BlackRock, Inc., with 10.2% of the company. In total, 677 funds and institutions reported holding THC at the end of Q2 2026, together about 94% of the shares. See the largest owners.
Are THC insiders buying or selling?
In the last 12 months, THC insiders reported no open-market purchases and 34 sales worth $63.2M. The latest trade was on Nov 11, 2026. See every trade.
What is the short interest in THC?
As of Oct 30, 2026, 1.78M THC shares were sold short, 2.2% of the shares outstanding, down 3.3% from the report before. At the average daily volume of 811,923 shares, buying them all back would take about 2.2 trading days (days to cover). See the history.
Have members of Congress traded THC?
Yes. 2 members of Congress reported 3 purchases and 4 sales of THC since Nov 17, 2024. The latest was reported on May 27, 2026. See the trades.
Which famous investors hold THC?
8 of the 50 well-known investors we track reported THC in their latest 13F filing, including Larry Robbins, Ken Griffin, Israel Englander. The largest position is worth $523M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.